Clinical Trials List
2008-11-15 - 2011-05-31
Phase II
Terminated5
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shian-Shiang Wang Division of Urology
- Jian-Ri Li Division of Urology
- Chuan-Shu Chen Division of Urology
- 熊小澐 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- - - Division of Radiology
- Yeong-Shiau Pu Division of Urology
- - - Division of Urology
- Chia-Chi Lin Division of Hematology & Oncology
- - - Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 莊恆彰 Division of Urology
- 張英勛 Division of Urology
- 莊昆隆 Division of Urology
- Rita cheng Division of Urology
- 吳俊德 Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- 王俐人 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 查岱龍 Division of Urology
- Tsu-Yi Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsiao-Jen Chung 未分科
- Tzu-Ping Lin Division of Urology
- 鐘孝仁 Division of Urology
- 鐘孝仁醫師 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
360 participants
